Navidea Biopharmaceuticals Cash from Investing (TTM) Insights

Navidea Biopharmaceuticals Inc (NAVB)

0.035 0.00 (0.00%) USD | OTCM | Apr 19, 15:21

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 1993. Upgrade now.

Date	Value
September 30, 2023	-0.7011M
June 30, 2023	-0.2554M
March 31, 2023	-0.3116M
December 31, 2022	-0.3903M
September 30, 2022	-0.4077M
June 30, 2022	-0.462M
March 31, 2022	-0.3801M
December 31, 2021	-0.3294M
September 30, 2021	-0.3226M
June 30, 2021	-0.3959M
March 31, 2021	-0.4159M
December 31, 2020	-0.4128M
September 30, 2020	-0.3882M
June 30, 2020	0.0199M
March 31, 2020	0.4791M
December 31, 2019	0.7704M
September 30, 2019	0.8015M
June 30, 2019	0.5838M
March 31, 2019	0.7807M
December 31, 2018	0.9538M
September 30, 2018	1.178M
June 30, 2018	1.171M
March 31, 2018	-1.434M
December 31, 2017	-1.834M
September 30, 2017	-2.031M

Date	Value
June 30, 2017	-2.008M
March 31, 2017	-0.0374M
December 31, 2016	-0.0392M
September 30, 2016	-0.0478M
June 30, 2016	-0.0497M
March 31, 2016	-0.0443M
December 31, 2015	-0.0278M
September 30, 2015	-0.0476M
June 30, 2015	-0.4198M
March 31, 2015	-0.5177M
December 31, 2014	-1.525M
September 30, 2014	-1.998M
June 30, 2014	-1.726M
March 31, 2014	-1.928M
December 31, 2013	-1.292M
September 30, 2013	-0.8393M
June 30, 2013	-0.9827M
March 31, 2013	-0.8873M
December 31, 2012	-0.6718M
September 30, 2012	-0.5566M
June 30, 2012	26.86M
March 31, 2012	27.08M
December 31, 2011	27.16M
September 30, 2011	27.06M
June 30, 2011	-0.2162M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-0.7011M

Minimum

Sep 2023

0.8015M

Maximum

Sep 2019

-0.1399M

Average

-0.3548M

Median

Cash from Investing (TTM) Benchmarks